Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: William Welch, Dirk van den Boom, Ron Lindsay, Frederic Walder

Premium

Sequenom has promoted several members of its management team. William Welch is now the president and chief operating officer. He was previously senior vice president of diagnostics and has overseen the commercial operations of the MaterniT21 Plus test. Dirk van den Boom has been appointed executive vice president of research and development and chief technology officer from his position of senior vice president of research and development, which he has held since 2010. He joined the company in 1998. Ron Lindsay is now executive vice president of strategic planning. He was previously the executive vice president of research and development.


Fluidigm has named Frederic Walder to serve as its chief operating officer. Walder has been chief business officer at Fluidigm since 2010. From 1992 to 2010, Walder held various senior executive posts at Thermo Fisher Scientific.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more